Free Kappa/Lambda Light Chains

Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the International Myeloma Working Group for use in the initial diagnostic workup of multiple myeloma and related disorders.^1-2

The International Myeloma Working Group Guidelines recommend that Freelite be used for monitoring oligosecretory plasma cell disorders and AL Amyloidosis.¹

 
Test Codes:

• 903371 - Free Kappa/Lambda Light Chains with Ratio, Serum
  
  
• 804319 - Monoclonal Gammopathy Dx Panel (SPE, TP, sFLC, IT)
  
  
• 804320 - Monoclonal Gammopathy Dx Panel w/Reflex IT (SPE, TP, sFLC)

• 804321 - Monoclonal Gammopathy Dx Panel, AL Amy (SPE, TP, sFLC, IT, uIFE)
  
  

Learn more about our Free Kappa/Lambda Light Chain testing

For more information on serum free light chain assays click on The Binding Site logo below

References

1. Dispenzieri A, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23:215-224.
   
   
2. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma V.1.2011. © 2010 National Comprehensive Cancer Network, Inc. All rights reserved.